RxDoctor Payments Data

Kelsie Goodwin, APRN

Acute Care · Mt Pleasant, SCNPI 1255067484

Payments from drug & device makers

$1,079in general payments, 2019–2025

Across 13 payments — averaging $82.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$243
  • AbbVie$242
  • Enterra Medical, Inc.$206
  • Bioxcel Therapeutics, Inc.$125
  • Medtronic$105
  • Chiesi USA, Inc.$81
  • plus $77 from 3 others

What the payments were for

  • Food & beverage$1,079100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Smith+Nephew2$243
AbbVie2$242
Enterra Medical, Inc.2$206
Bioxcel Therapeutics, Inc.1$125
Medtronic2$105
Chiesi USA, Inc.1$81
Stryker1$38
RARE Disease Therapeutics, Inc.1$23
Genentech USA, Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,079 in reported general payments places this provider in the 60th percentile of 339 acute care providers in South Carolina.

See all acute care providers in South Carolina

Medicare billing

Part B allowed, 2024
$6,035
Medicare patients
66
Services billed
69

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate46$7,021
Omeprazole140$2,365
Ondansetron OdtOndansetron71$1,426
Famotidine58$806
Promethazine Hcl30$428
Nystatin30$342
Methocarbamol22$331
Pantoprazole Sodium25$321
Ondansetron Hcl11$244
NystopNystatin12$159
Tramadol Hcl19$96
Vitamin D2Ergocalciferol (Vitamin D2)11$68

Paid to pharmacies, not to this prescriber.

Other acute care in Mt Pleasant

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →